Found 7 matching trials
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS. PHASE2 The purpose of this study is to learn about the safety and effects of the s...
Show More Location
Medical Dermatology Specialists
Learn More & Join Trial
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease PHASE2 The objectives of this study are to evaluate the efficacy, safety, tolerabi...
Show More Location
Dothan Surgery Center
Learn More & Join Trial
PF-06651600 for the Treatment of Alopecia Areata PHASE2 This is a global Phase 2b/3 study to evaluate the safety and effectiveness ...
Show More Location
The University of Alabama at Birmingham Hospital Outreach Lab
Learn More & Join Trial
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis PHASE2 The purpose of this study is to determine whether PF-06651600 and PF-067008...
Show More Location
Dothan Surgery Center
Learn More & Join Trial
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata PHASE3 The purpose of the study is to learn about the safety and effects of the st...
Show More Location
The Kirklin Clinic of UAB Hospital (Radiology)
Learn More & Join Trial
Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers PHASE1 This study is a first in human study of PF-06651600. PF-06651600 is being d...
Show More Location
Pfizer Clinical Research Unit
Learn More & Join Trial
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA PHASE2 This is a global Phase 2a randomized, double-blind, placebo-controlled stud...
Show More Location
Marvel Clinical Research 002, LLC
Learn More & Join Trial